Style | Citing Format |
---|---|
MLA | Elyasinia F, et al.. "The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients With Obesity." Middle East Journal of Digestive Diseases, vol. 13, no. 3, 2021, pp. 200-207. |
APA | Elyasinia F, Jalali SM, Zarini S, Sadeghian E, Sorush A, Pirouz A (2021). The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients With Obesity. Middle East Journal of Digestive Diseases, 13(3), 200-207. |
Chicago | Elyasinia F, Jalali SM, Zarini S, Sadeghian E, Sorush A, Pirouz A. "The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients With Obesity." Middle East Journal of Digestive Diseases 13, no. 3 (2021): 200-207. |
Harvard | Elyasinia F et al. (2021) 'The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients With Obesity', Middle East Journal of Digestive Diseases, 13(3), pp. 200-207. |
Vancouver | Elyasinia F, Jalali SM, Zarini S, Sadeghian E, Sorush A, Pirouz A. The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients With Obesity. Middle East Journal of Digestive Diseases. 2021;13(3):200-207. |
BibTex | @article{ author = {Elyasinia F and Jalali SM and Zarini S and Sadeghian E and Sorush A and Pirouz A}, title = {The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients With Obesity}, journal = {Middle East Journal of Digestive Diseases}, volume = {13}, number = {3}, pages = {200-207}, year = {2021} } |
RIS | TY - JOUR AU - Elyasinia F AU - Jalali SM AU - Zarini S AU - Sadeghian E AU - Sorush A AU - Pirouz A TI - The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients With Obesity JO - Middle East Journal of Digestive Diseases VL - 13 IS - 3 SP - 200 EP - 207 PY - 2021 ER - |